Sterling Capital Management LLC

Position in TEVA — Teva Pharmaceutical Industries Ltd

CIK 1329883 CHARLOTTE, NC

Back to TEVA Full portfolio

Position in TEVA

as of Mar 31, 2026 · filed Apr 22, 2026 Compact

Position Value

$13,583,878

-$13,231,379 QoQ

Shares Held

450,992

-47.5% QoQ

Ownership

0.039%

of shares outstanding

% of Portfolio

0.31%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2024

7 quarters on record

Voting authority Sole 99.83081739809133.ToString("F0")% Shared 0.ToString("F0")% None 0.1691826019086813.ToString("F0")%

Common Shares in TEVA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Sterling Capital Management LLC holds $21,914,421 across 40 Drug Manufacturers - Specialty & Generic names. TEVA ranks #1 (62.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TEVA	Teva Pharmaceutical Industries Ltd This page	450,992	$13,583,878
2	VTRS	Viatris Inc	232,342	$3,138,940
3	ZTS	Zoetis Inc.	8,983	$1,061,880
4	HLN	Haleon plc	94,183	$942,771
5	UTHR	UNITED THERAPEUTICS Corp	1,429	$847,368
6	ELAN	Elanco Animal Health Inc	16,596	$397,142
7	AMRX	Amneal Pharmaceuticals, Inc.	22,625	$281,228
8	PCRX	Pacira BioSciences, Inc.	11,270	$254,702

All Filings in TEVA

Export CSV

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$13,583,878	450,992	-47.5%	Shares	Sole	2026-04-22
2025-12-31	$26,815,257	859,188	-42.8%	Shares	Sole	2026-02-13
2025-09-30	$30,333,552	1,501,661	+0.9%	Shares	Sole	2025-11-12
2025-06-30	$24,938,410	1,487,972	-27.1%	Shares	Sole	2025-08-08
2025-03-31	$31,358,411	2,040,235	-1.5%	Shares	Sole	2025-05-13
2024-12-31	$45,663,640	2,071,853	-10.3%	Shares	Sole	2025-02-13
2024-09-30	$41,608,936	2,309,042	—	Shares	Sole	2024-11-12
No filing history on record for this holder in this stock.